|
Cytocybernetics, Inc.
Cytocybernetics developed and sells the Cybercyte, a device that integrates electronics with individual cells to test how new medicines affect the cell’s electrical activity. By linking the Cybercyte to heart muscle cells, scientists can test all kinds of pharmaceuticals, from allergy medications to antidepressants, for potentially fatal side...
Category(s): Technology Classifications > Biomedical Science and Engineering, Technology Classifications > Medical Devices, Campus > University at Buffalo
|
|
|
Bionet Sonar, Inc.
Bionet Sonar's vision is to enable The Internet of Medical Things by developing a new generation of smart medical implants with sensing and wireless connectivity based on ultrasonic waves instead of traditional RF microwaves used in Bluetooth or WiFi. www.bionetsonar.com
Category(s): Technology Classifications > Medical Devices, Technology Classifications > Wireless Technologies, Campus > University at Buffalo
|
|
|
PoP Biotechnologies, Inc.
PoP Biotechnologies, Inc focuses on a scalable and low cost process to develop nanomedicines and medical technologies that have unique chemical and physical properties. www.popbiotech.com
Category(s): Technology Classifications > Biomedical Science and Engineering, Technology Classifications > Nanotechnology, Campus > University at Buffalo
|
|
|
Photolitec, LLC
Photolitec is developing a "see and treat" approach for the treatment of cancer with photosensitizing compounds. Also, Photolitec has the goal of improving tumor imaging, response and treatment. www.photolitec.org
Category(s): Technology Classifications > Biomedical Science and Engineering, Technology Classifications > Medical Imaging, Technology Classifications > Medical Devices, Campus > University at Buffalo
|
|
|
Simulated Surgical Systems, LLC
Simulated Surgical Systems is focused on the development of devices to be used in robot assisted surgeries. The goal is to reduce surgical errors and use robots in surgical education. www.simulatedsurgicals.com
Category(s): Technology Classifications > Education and Training, Technology Classifications > Medical Devices, Campus > University at Buffalo
|
|
|
PLS 3rd Learning
PLS 3rd Learning focuses on developing tech-based systems to improve teaching and learning in K-12 schools. Partnership with educational organizations help reach many people and make the system more effective. www.pls3rdlearning.com
Category(s): Technology Classifications > Education and Training, Technology Classifications > Electronics, Campus > University at Buffalo
|
|
|
Athenex, Inc.
Athenex is a global biopharmaceutical company that has a goal of establishing better cancer treatments to improve health outcomes. www.athenex.org
Category(s): Technology Classifications > Biomedical Science and Engineering, Campus > University at Buffalo
|
|
|
Nanobiotix
Nanobiotix uses therapeutic technologies based on physical principles at nanoscale to discover approaches to improving treatment outcomes. Nanobiotix designs and manufactures nanoparticles that safley enhance the efficiacy of radiation therapy in the treatment of cancer. This will improve the efficiency of radiation in tumor cells for patients and hopefully...
Category(s): Technology Classifications > Biomedical Science and Engineering, Technology Classifications > Therapeutics and Vaccines, Technology Classifications > Nanotechnology, Campus > University at Buffalo
|
|
|
You First Services, Inc.
You First Services, Inc. was created for the purpose of acquiring and commercializing unique, high market-potential medical device related technologies that have been successfully developed in a research laboratory setting and have not yet been subject to full evaluation for commercial value potential with respect to formulation development, stability...
Category(s): Technology Classifications > Medical Devices, Technology Classifications > Healthcare IT, Campus > University at Buffalo
|
|
|
Tonus Therapeutics
Tonus Therapeutics has developed a drug to treat Duchenne Muscular Dystrophy which occurs in 1 in every 3500 boys. There is no cure for this disease and it is a progressive disease with a life span of about 25 years. Our drug will slow the degradation of the muscles to keep the boys walking longer. www.tonustherapeutics.com
Category(s): Technology Classifications > Drug Delivery, Technology Classifications > Healthcare, Campus > University at Buffalo
|
|